{"disease":{"id":"proprotein-convertase-subtilisin-kexin-9","name":"proprotein convertase subtilisin kexin 9"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05976893","title":"Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":620,"lead_sponsor_name":"Xiang Xie","has_results":false},{"nct_id":"NCT04100434","title":"Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Tianjin Chest Hospital","has_results":false},{"nct_id":"NCT04948008","title":"Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":8,"lead_sponsor_name":"Shenzhen People's Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}